23.03.2016
- J. Michael Pearson has stepped down as CEO of Canada-based Valeant Pharmaceuticals two months after returning from a medical leave, as the company’s stock continues to bleed. One...
21.03.2016
- The former general counsel of Turing Pharmaceuticals said on Thursday that he and other executives had repeatedly objected to a plan by Martin Shkreli, then chief executive, to...
03.03.2016
- Canada-based, US-managed drug firm Valeant Pharmaceuticals has confirmed it is under another investigation by the Securities and Exchange Commission (SEC), the latest in a string...
26.02.2016
- A jury hearing a claim in a Missouri state circuit court against US healthcare giant Johnson & Johnson (J&J) has found the company liable for fraud, negligence and conspiracy in...
29.01.2016
- The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...
04.01.2016
- Pershing Square Capital Management, the hedge fund of billionaire US activist investor Bill Ackman, has trimmed its stake in Canada-headquartered Valeant Pharmaceuticals from...
03.11.2015
- Canadian drugmaker Valeant has said it will sever ties with Philidor, the specialty pharmacy it has been accused of using to falsify sales and drive selling prices. The company’s...
28.10.2015
- Novartis has agreed to pay $390 million to settle with the US Department of Justice over allegations it used kickbacks to specialist pharmacies to promote sales of some of its...
